This week it was announced that Noblis has sold RASMAS to Inmar, a leading provider of recall and product withdrawal services for both pharmaceutical and consumer goods in the U.S. and Canada. RASMAS was developed by Noblis and is a web-based subscription service which provides comprehensive notification, distribution, organization, and management of product alerts and recalls throughout the healthcare industry.
Noblis and RASMAS share a long history. Inmar has served as the exclusive reseller of RASMAS for eight years. RASMAS helps its pharmacy clients reduce alert processing time by up to 80 percent – decreasing patient exposure to potentially harmful products. The RASMAS system automatically notifies users when they are affected by recalls by comparing purchase history information with each notification released to increase efficiency and enable products to be removed from shelves faster.
“Noblis is proud of the impact we’ve made on patient safety through the development of RASMAS,” said Amr ElSawy, Noblis President and CEO. “Inmar has a deep understanding and appreciation of RASMAS and the value it provides to its customers and to patients. We are pleased to know that this important service will continue to grow and evolve as part of their services.”
Read the full news release here.